The Danish metastatic melanoma database (DAMMED) : A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients
Copyright © 2021 Elsevier Ltd. All rights reserved..
BACKGROUND: Clinical trials enroll patients with specific diseases based on certain pre-defined eligibility criteria. Disease registries are crucial to evaluate the efficacy and safety of new expensive oncology medicines in broad non-trial patient populations.
METHODS: We provide detailed information on the structure, including variables, and the scientific results from a nation-wide Danish database covering advanced melanoma, illustrating the importance of continuous real-world data registration. Disease status and treatment-related information on all patients with American Joint Committee on Cancer (AJCC) 8th edition stage III or IV melanoma candidates to medical treatment in Denmark are prospectively registered in the Danish Metastatic Melanoma Database (DAMMED).
RESULTS: By January 1st, 2021, DAMMED includes 4156 patients and 7420 treatment regimens. Response rates and survival data from published randomized clinical trial data are compared with real-world efficacy data from DAMMED and presented. Overall, nine independent manuscripts highlighting similarities and discrepancies between real-world and clinical trial results are already reported to date.
CONCLUSION: Nation-wide disease registries take into consideration the complexity of daily clinical practice. We show a concrete example of how disease registries can complement clinical trials' information, improving clinical practice, and support health-related technology assessment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Cancer epidemiology - 73(2021) vom: 09. Aug., Seite 101943 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ellebaek, Eva [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adjuvant therapy |
|---|
| Anmerkungen: |
Date Completed 27.08.2021 Date Revised 27.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.canep.2021.101943 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325141754 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325141754 | ||
| 003 | DE-627 | ||
| 005 | 20231225191816.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.canep.2021.101943 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1083.xml |
| 035 | |a (DE-627)NLM325141754 | ||
| 035 | |a (NLM)33962356 | ||
| 035 | |a (PII)S1877-7821(21)00060-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ellebaek, Eva |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Danish metastatic melanoma database (DAMMED) |b A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.08.2021 | ||
| 500 | |a Date Revised 27.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: Clinical trials enroll patients with specific diseases based on certain pre-defined eligibility criteria. Disease registries are crucial to evaluate the efficacy and safety of new expensive oncology medicines in broad non-trial patient populations | ||
| 520 | |a METHODS: We provide detailed information on the structure, including variables, and the scientific results from a nation-wide Danish database covering advanced melanoma, illustrating the importance of continuous real-world data registration. Disease status and treatment-related information on all patients with American Joint Committee on Cancer (AJCC) 8th edition stage III or IV melanoma candidates to medical treatment in Denmark are prospectively registered in the Danish Metastatic Melanoma Database (DAMMED) | ||
| 520 | |a RESULTS: By January 1st, 2021, DAMMED includes 4156 patients and 7420 treatment regimens. Response rates and survival data from published randomized clinical trial data are compared with real-world efficacy data from DAMMED and presented. Overall, nine independent manuscripts highlighting similarities and discrepancies between real-world and clinical trial results are already reported to date | ||
| 520 | |a CONCLUSION: Nation-wide disease registries take into consideration the complexity of daily clinical practice. We show a concrete example of how disease registries can complement clinical trials' information, improving clinical practice, and support health-related technology assessment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Adjuvant therapy | |
| 650 | 4 | |a Database structure | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Metastatic melanoma | |
| 650 | 4 | |a Real-world evidence | |
| 650 | 4 | |a Targeted therapy | |
| 700 | 1 | |a Svane, Inge Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt, Henrik |e verfasserin |4 aut | |
| 700 | 1 | |a Haslund, Charlotte Aaquist |e verfasserin |4 aut | |
| 700 | 1 | |a Donia, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Hoejberg, Lise |e verfasserin |4 aut | |
| 700 | 1 | |a Ruhlmann, Christina |e verfasserin |4 aut | |
| 700 | 1 | |a Guldbrandt, Louise Mahncke |e verfasserin |4 aut | |
| 700 | 1 | |a Køhler, Ulrich Heide |e verfasserin |4 aut | |
| 700 | 1 | |a Bastholt, Lars |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer epidemiology |d 2009 |g 73(2021) vom: 09. Aug., Seite 101943 |w (DE-627)NLM18889912X |x 1877-783X |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2021 |g day:09 |g month:08 |g pages:101943 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.canep.2021.101943 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2021 |b 09 |c 08 |h 101943 | ||